| UHC Medicaid Medical & Drug | Surgery of the Hip – Community Plan Medical Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Synagis® (Palivizumab) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Tepezza® (Teprotumumab-Trbw) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Tezspire® (Tezepelumab-Ekko) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Uplizna® (Inebilizumab-Cdon) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Vyjuvek® (Beramagene Geperpavec-Svdt) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Xiaflex® (Collagenase Clostridium Histolyticum) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Xolair® (Omalizumab) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Zolgensma® (Onasemnogene Abeparvovec-Xioi) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| Ambetter Health Louisiana Clinical | Disc Decompression Procedures | 2026-04-01 |